Catheter Precision, Inc. Contract Liability (Deferred Revenue)
Catheter Precision, Inc. (VTAK) had Contract Liability (Deferred Revenue) of $145.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2026-08-14
- 2026-06-30: Contract with Customer, Liability, Current $145.00K.
- 2026-03-31: Contract with Customer, Liability, Current $126.00K.
- 2025-12-31: Contract with Customer, Liability, Current $0.00.
- 2021-06-30: Contract with Customer, Liability, Current $1.79M.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2026-06-30 | $145.00K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $126.00K 10-Q · filed 2026-05-18 |
| 2025-12-31 | $0.00 10-Q · filed 2026-08-14 |
| 2021-06-30 | $1.79M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $1.78M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $1.80M 10-Q · filed 2021-08-11 |
| 2020-09-30 | $1.73M 10-Q · filed 2020-11-16 |
| 2020-06-30 | $1.86M 10-Q · filed 2020-08-11 |
| 2020-03-31 | $1.96M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $2.03M 10-K · filed 2021-03-17 |
| 2019-09-30 | $1.92M 10-Q · filed 2019-11-29 |
| 2019-06-30 | $2.04M 10-Q · filed 2019-11-29 |
| 2019-03-31 | $1.95M 10-Q · filed 2019-05-14 |
| 2018-12-31 | $1.72M 10-K · filed 2020-03-11 |
| 2017-12-31 | $1.71M 10-K · filed 2019-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |